pI: 5.9314 |
Length (AA): 441 |
MW (Da): 52181 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There is 1 model calculated for this protein. More info on
this model, including the
model itself is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
83 | 441 | 3c5i (A) | 11 | 369 | 70.00 | 0 | 1 | 1.71786 | -1.52 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Gametocyte, 22 hs Schizont, Male gametocyte. | Otto TD Yeoh LM |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | 4 hs Ring, Erthyrocytic stages, Female gametocyte. | Otto TD Yeoh LM |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Ookinete, 16 hs Trophozoite. | Otto TD |
Otto TD | A comprehensive evaluation of rodent malaria parasite genomes and gene expression. |
Yeoh LM | Comparative transcriptomics of female and male gametocytes in Plasmodium berghei and the evolution of sex in alveolates. |
Ortholog group members (OG5_127835)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G71697 | choline kinase 1 |
Arabidopsis thaliana | AT4G09760 | choline synthase |
Arabidopsis thaliana | AT1G74320 | choline kinase |
Brugia malayi | Bm1_38730 | Choline/ethanolamine kinase family protein |
Candida albicans | CaO19.6966 | likely choline kinase similar to S. cerevisiae CKI1 (YLR133W) |
Caenorhabditis elegans | CELE_C52B9.1 | Protein CKA-2, isoform B |
Cryptosporidium hominis | Chro.30240 | choline kinase GmCK2p-like protein |
Cryptosporidium parvum | cgd3_2030 | putative choline kinase |
Drosophila melanogaster | Dmel_CG2201 | CG2201 gene product from transcript CG2201-RF |
Echinococcus granulosus | EgrG_001007100 | choline:ethanolamine kinase |
Echinococcus multilocularis | EmuJ_001007100 | choline:ethanolamine kinase |
Homo sapiens | ENSG00000110721 | choline kinase alpha |
Homo sapiens | ENSG00000100288 | choline kinase beta |
Loa Loa (eye worm) | LOAG_06124 | choline/ethanolamine kinase |
Mus musculus | ENSMUSG00000024843 | choline kinase alpha |
Mus musculus | ENSMUSG00000022617 | choline kinase beta |
Neospora caninum | NCLIV_009640 | choline kinase, putative |
Oryza sativa | 9268113 | Os05g0535400 |
Oryza sativa | 4325332 | Os01g0183000 |
Oryza sativa | 4325586 | Os01g0717000 |
Plasmodium berghei | PBANKA_1040100 | choline kinase |
Plasmodium falciparum | PF3D7_1401800 | choline kinase |
Plasmodium knowlesi | PKNH_1356300 | choline kinase, putative |
Plasmodium vivax | PVX_086340 | choline kinase, putative |
Plasmodium yoelii | PY00116 | choline kinase GmCK2p-like protein, putative |
Saccharomyces cerevisiae | YLR133W | bifunctional choline kinase/ethanolamine kinase CKI1 |
Saccharomyces cerevisiae | YDR147W | bifunctional choline kinase/ethanolamine kinase EKI1 |
Schistosoma japonicum | Sjp_0090310 | ko:K00866 choline kinase [EC2.7.1.32], putative |
Toxoplasma gondii | TGME49_320630 | phosphotransferase enzyme family protein |
Theileria parva | TP02_0657 | choline kinase, putative |
Theileria parva | TP02_0660 | choline kinase, putative |
Theileria parva | TP02_0659 | choline kinase, putative |
Theileria parva | TP02_0656 | choline kinase, putative |
Theileria parva | TP02_0658 | choline kinase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
PBANKA_1040100 this record | Plasmodium berghei | Slow | plasmo |
TGME49_320630 | Toxoplasma gondii | Probably non-essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | choline kinase alpha | Compounds | References |